Anesthesiology and Pain Medicine

Published by: Kowsar

Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial

Mahmood Hosseinzadeh Maleki 1 , Pooya Derakhshan 2 , * , Amir Rahmanian Sharifabad 1 and Ahmad Amouzeshi 1
Authors Information
1 Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Anesthesiology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Anesthesiology and Pain Medicine: February 01, 2016, 6 (1); e30326
  • Published Online: January 18, 2016
  • Article Type: Research Article
  • Received: May 29, 2015
  • Revised: July 26, 2015
  • Accepted: August 17, 2015
  • DOI: 10.5812/aapm.30326

To Cite: Hosseinzadeh Maleki M, Derakhshan P, Rahmanian Sharifabad A, Amouzeshi A. Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial, Anesth Pain Med. 2016 ; 6(1):e30326. doi: 10.5812/aapm.30326.

Abstract
Copyright © 2016, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010; 76(8): 584-91[PubMed]
  • 2. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003; 54(3): 207-15[PubMed]
  • 3. Langeron O, Doelberg M, Ang E, Bonnet F, Capdevila X, Coriat P. Voluven??, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5. Anesth Analg. 2001; : 855-62[DOI]
  • 4. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000; 47(12): 1207-15[PubMed]
  • 5. Arellano R, Gan BS, Salpeter MJ, Yeo E, McCluskey S, Pinto R, et al. A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg. 2005; 100(6): 1846-53[DOI][PubMed]
  • 6. Baldassarre S, Vincent JL. Coagulopathy induced by hydroxyethyl starch. Anesth Analg. 1997; 84(2): 451-3[PubMed]
  • 7. Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS, Kron IL, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg. 1997; 63(1): 78-82[PubMed]
  • 8. Payani N, Foroughi M, Dabbagh A. The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial. Anesth Pain Med. 2015; 5(1)[DOI][PubMed]
  • 9. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, et al. Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery? Anesth Analg. 2000; 9(4): 801-7[DOI]
  • 10. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012; 144(1): 223-30[DOI][PubMed]
  • 11. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006; 102(4): 998-1006[DOI][PubMed]
  • 12. Onorati F, Santarpino G, Renzulli A, De Feo M, De Santo LS, Della Corte A, et al. Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass? Int J Artif Organs. 2003; 26(3): 211-6[PubMed]
  • 13. Tigchelaar I, Huet RCG, Boonstra PW, van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion. 1998; 13(5): 297-303[DOI]
  • 14. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg. 2009; 60(2): 91-7[PubMed]
  • 15. Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg. 2005; 56(3): 257-63[PubMed]
  • 16. Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux JP, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014; 18(6): 602[DOI][PubMed]
  • 17. Kumar AB, Suneja M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011; 114(4): 964-70[DOI][PubMed]
  • 18. Joudi M, Fathi M, Soltani G, Izanloo A. Factors affecting on serum lactate after cardiac surgery. Anesth Pain Med. 2014; 4(4)[DOI][PubMed]
  • 19. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001; 135(3): 149-64[PubMed]
  • 20. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008; 31(2): 166-78[PubMed]
  • 21. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008; 3: 45[DOI][PubMed]
  • 22. Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010; 1(2): 67-9[PubMed]
  • 23. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004; 98(2): 291-7[PubMed]
  • 24. Brinkman AC, Romijn JW, van Barneveld LJ, Greuters S, Veerhoek D, Vonk AB, et al. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth. 2010; 24(3): 422-6[DOI][PubMed]
  • 25. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001; 72(2): 527-33[PubMed]
  • 26. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014; 112(2): 255-64[DOI][PubMed]
  • 27. Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1997; 11(4): 626-32[PubMed]
  • 28. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013; 116(1): 35-48[DOI][PubMed]
  • 29. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not. Anesth Analg. 1997; 84(1): 206-12
  • 30. Weiskopf RB. Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology. 2013; 119(6): 1249-54[DOI][PubMed]
  • 31. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001; 29(6): 1261-7[PubMed]
  • 32. Van der Linden P, De Ville A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130/0.4 (Voluven(R)) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology. 2013; 119(6): 1296-309[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments